July 17, 2017 10:00 AM EDT
R&D
Pharma

FDA's Scott Got­tlieb is field­ing a new team of re­cruiters to start scout­ing top tal­ent

John Carroll

Editor & Founder

Biotech ex­ecs have been bull­ish sup­port­ers of the FDA in re­cent years, of­fer­ing their ap­pre­ci­a­tion of faster re­view times with new pro­grams like the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times